1.Awareness of Glycosylated Haemoglobin (HbA1c) Among Type 2 Diabetes Mellitus Patients in Hospital Putrajaya
Intan Nureslyna Samsudin ; Subashini C. Thambiah ; Wan Mohamad Asyraf Wan Mohammed Ayub ; Ng Wan Cheng ; Zanariah Hussein ; Nurain Mohd Noor ; Masni Mohamad ; Elizabeth George
Malaysian Journal of Medicine and Health Sciences 2015;11(2):1-8
The glycosylated haemoglobin (HbA1c) test is the most widely accepted laboratory test for evaluating
long term glycaemic control. Patient’s understanding of HbA1c can lead to better glycaemic control.
This study is aimed to determine the awareness and level of understanding of HbA1c among type 2 DM
patients and its association with glycaemic control. A cross-sectional descriptive study among Type 2
DM patients undergoing routine follow up in an endocrine clinic of a tertiary centre in Malaysia. Patients
were invited to answer a validated questionnaire which assessed their awareness and understanding of
HbA1c. Their last HbA1c results were retrieved from the laboratory information system. A total of
92 participants were recruited. Fifty-six (60.9%) were aware of the term HbA1c. Fifty percent were
categorised as having good HbA1c understanding, with age, monthly income and level of education
being the factors associated with understanding. No significant association was noted between HbA1c
understanding and glycaemic control, although more patients with good HbA1c understanding had
achieved the target glycaemic control compared to those with poor understanding. The level of HbA1c
awareness and understanding was acceptable. Factors associated with understanding were age, income
and level of education. Continuing efforts however, must be made to improve patients understanding of
their disease and clinical disease biomarkers.
Diabetes Mellitus, Type 2
2.Anaemia in Type 2 Diabetes Mellitus (T2DM) Patients in Hospital Putrajaya
Subashini Chellappah Thambiah ; Intan Nureslyna Samsudin ; Elizabeth George ; Lydiar Kaur Ranjit ; Nur Syakila Saat ; Zanariah Hussein ; Nurain Mohd Noor ; Masni Mohamad
Malaysian Journal of Medicine and Health Sciences 2015;11(1):49-62
Patients with diabetes have an earlier onset and increased severity of anaemia compared to those with
similar degree of renal impairment from other causes. Anaemia is associated with an increased risk
of vascular complications. In this study, we determined the prevalence of anaemia in T2DM patients
and its association with sociodemographic, clinical and laboratory parameters in an endocrine tertiary
hospital in Malaysia. This was a cross-sectional study using retrospective electronic data from January
2011 to December 2013 of 165 T2DM patients in Hospital Putrajaya. Data was analysed using IBM
SPSS Statistics version 21.0 for Windows. The prevalence of anaemia was 39.4% and majority had
normocytic normochromic (80%), mild (58.5%) anaemia. Majority were Malays (73.9%), aged below
60 with comparable gender percentage and long-standing, poorly-controlled DM [median fasting blood
sugar (FBS) 8mmol/L; glycated haemoglobin (HbA1c) 7.9%]. Using the KDIGO chronic kidney disease
(CKD) staging system, 86% of these patients were in stages 3-5. Anaemic patients had a significantly
higher serum urea, creatinine and a lower FBS, estimated glomerular filtration rate (eGFR) compared to
non-anaemic patients. Anaemic patients with diabetic nephropathy had a significantly lower haemoglobin
(Hb) compared to those without this complication (p=0.022). The sensitivity and specificity at a cut-off
eGFR value of 38.3 ml/min/1.73 m2 (maximum Youden index = 0.462) was 66.7% and 79.5%, respectively
to discriminate mild from moderate anaemia. This study shows that anaemia is already present in T2DM
patients in Hospital Putrajaya at initial presentation to the specialist outpatient clinic and is significantly
associated with CKD. Hence, it emphasises the obligatory need for routine and follow-up full blood
count monitoring in T2DM patients in primary care as well as tertiary settings in Malaysia to enable
early detection and aggressive correction of anaemia in preventing further complications.
Diabetes Mellitus, Type 2
3.Relationship Between Dyslipidaemia And Glycaemic Status In Patients With Type 2 Diabetes Mellitus
Subashini C Thambiah Mbbs ; Intan Nureslyna Samsudin ; Elizabeth George ; Siti Yazmin Zahari Sham ; Huey Ming Lee ; Mohd Azril Muhamad ; Zanariah Hussein ; Nurain Mohd Noor ; Masni Mohamad
The Malaysian Journal of Pathology 2016;38(2):123-130
The risk of coronary heart disease (CHD) is dramatically increased in diabetic patients due to their
atherogenic lipid profile. The severity of CHD in diabetic patients has been found to be directly
associated with glycated haemoglobin (HbA1c). According to the Malaysian Clinical Practice
Guidelines on diabetes mellitus (DM), HbA1c level less than 6.5% reduces the risk of microvascular
and macrovascular complications. Hence, this study aimed to determine the relationship between
dyslipidaemia and glycaemic status in patients with type 2 DM (T2DM) patients in Hospital
Putrajaya, a tertiary endocrine centre in Malaysia. This was a cross sectional, retrospective study of
214 T2DM patients with dyslipidaemia who had visited the endocrine clinic between January 2009
and December 2012. Significant correlations were found between fasting blood glucose (FBG) and
HbA1c with total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL),
non-high density lipoprotein cholesterol (non-HDL), LDL/HDL ratio and TC/HDL ratio; greater
correlation being with HbA1c than FBG. In patients with HbA1c ≥ 6.5%, TC, TG, non-HDL and
TC/HDL ratio were significantly higher than in patients with HbA1c < 6.5%. Non-HDL, LDL/HDL
ratio, TC/HDL ratio and HbA1c were significantly lower in patients on statin treatment than nontreated
patients (p<0.05). This significant association between glycaemic status and dyslipidaemia
emphasises the additional possible use of HbA1c as a biomarker for dyslipidaemia as well as a
potential indirect predictor of cardiovascular disease (CVD) risk in T2DM patients.
4.Acute Suppurative Thyroiditis Secondary to Tuberculosis with Superimposed Bacterial Infection: A case report
Siti Sanaa binti Wan Azman ; Masni binti Mohamad
Journal of the ASEAN Federation of Endocrine Societies 2021;36(2):209-212
Acute suppurative thyroiditis is a rare and potentially fatal condition. We present a case of an 18-year-old Malay female who presented with one-week history of painful right sided neck swelling, fever and odynophagia. Neck CT confirms ruptured multiloculated abscess with posterosuperior extension into prevertebral space. Pus and tissue cultured Streptococcus anginosus and Eikenella corrodens with positive TB PCR. She responded well to ampicillin/sulbactam and anti-tuberculosis treatment with no evidence of residual collection from ultrasound.
Thyroiditis, Suppurative
5.Parathyroid Carcinoma: Analysis of patient characteristics and outcomes in a retrospective review of eight cases seen in a single center
Shamira Shahar ; Kim Piow Lim ; Masni Mohamad
Journal of the ASEAN Federation of Endocrine Societies 2019;34(2):229-232
Eight cases of parathyroid carcinoma were identified (8 females; median age 45 years, range 28-72). Half of whom were diagnosed preoperatively. Hypercalcemic symptoms were seen in 87.5% of the patients and the main complication was nephrolithiasis. At presentation, the median calcium was 3.675 mmol/L, median phosphate of 0.68 mmol/L, median intact parathyroid hormone (iPTH) was 211 pmol/L. Five patients had regional nodes metastasis and 1 had distant metastasis to the lungs. Parathyroid gland invasion to adjacent structures was seen in 62.5% of cases while another 62.5% showed capsular or vascular infiltration on histology with median tumour size of 3.2 cm. Recurrent hypercalcemia occurred in 50% of the patients with median time of recurrence of 21 months. In this case series, we found that patients with severe hypercalcemia and high iPTH also exhibited a high index suspicion of PC.
Parathyroid Neoplasms
;
Carcinoma
;
Hypercalcemia
6.Use of combination of Oral Levothyroxine and Liothyronine in severe Hypothyroidism with Massive Pericardial Effusion
Poh Shean Wong ; Sue Wen Lim ; Chin Voon Tong ; Masni Mohamad ; Zanariah Hussein
Journal of the ASEAN Federation of Endocrine Societies 2022;37(2):106-112
Thyroid hormone plays an important role in cardiovascular function. Pericardial effusions are commonly seen in cases of severe hypothyroidism. However, large to massive pericardial effusions with cardiac tamponade are exceptionally rare. Herein, we present two cases of severe hypothyroidism with massive pericardial effusion. Our first case demonstrates that a patient with large pericardial effusion can be managed conservatively with aggressive thyroid hormone replacement therapy. In our second case, pericardiocentesis was performed in addition to thyroid hormone replacement therapy as the underlying aetiology of effusion could not be reasonably limited to hypothyroidism. These two cases served to highlight and demonstrate rapid normalisation of thyroid function test by using aggressive oral thyroid hormone replacement therapy using liothyronine, in combination with levothyroxine, which led to resolution of pericardial effusion and prevent its re-accumulation.
Pericardial Effusion
;
Thyroxine
;
Triiodothyronine